Education
About Us
Working with TipRanks
Follow Us
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
BNTC Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BNTC Stock 12 Month Forecast
Average Price Target
$26.00
▲(128.47% Upside)
| Highest Price Target$32.00 | Average Price Target$26.00 | Lowest Price Target$20.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$35→$32
Buy
181.20%
Upside
Reiterated
11/24/25
TD Cowen
―
Buy
―
Reiterated
11/18/25
Benitec Biopharma: Strong Financial Position and Promising Clinical Developments Justify Buy RatingWe estimate current pro forma cash of ~$182M ($95M end of 3Q25 with additional $94M from a Nov. equity raise) gives runway into 2028, covering BNTC's ongoing '301 Ph1b/2a trial and registrational trial start in 2H26. BNTC is on track to meet with FDA in mid-2026 to align on '301's pivotal trial design and proprietary (and KOL supported) 5-point responder index proposed as the 1º EP.
Citizens JMP
$20→$22
Buy
93.32%
Upside
Reiterated
11/04/25
Piper Sandler
$30
Buy
163.62%
Upside
Reiterated
09/24/25
Leerink Partners
$20
Buy
75.75%
Upside
Reiterated
09/23/25
Oppenheimer
$35→$29
Buy
154.83%
Upside
Reiterated
09/16/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$35→$32
Buy
181.20%
Upside
Reiterated
11/24/25
TD Cowen
―
Buy
―
Reiterated
11/18/25
Benitec Biopharma: Strong Financial Position and Promising Clinical Developments Justify Buy RatingWe estimate current pro forma cash of ~$182M ($95M end of 3Q25 with additional $94M from a Nov. equity raise) gives runway into 2028, covering BNTC's ongoing '301 Ph1b/2a trial and registrational trial start in 2H26. BNTC is on track to meet with FDA in mid-2026 to align on '301's pivotal trial design and proprietary (and KOL supported) 5-point responder index proposed as the 1º EP.
Citizens JMP
$20→$22
Buy
93.32%
Upside
Reiterated
11/04/25
Piper Sandler
$30
Buy
163.62%
Upside
Reiterated
09/24/25
Leerink Partners
$20
Buy
75.75%
Upside
Reiterated
09/23/25
Oppenheimer
$35→$29
Buy
154.83%
Upside
Reiterated
09/16/25
Best Analysts Covering Benitec Biopharma
1 Month
xxx
Success Rate
7/9 ratings generated profit
Average Return
+9.89%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 77.78% of your transactions generating a profit, with an average return of +9.89% per trade.
3 Months
xxx
Success Rate
7/9 ratings generated profit
Average Return
+9.08%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +9.08% per trade.
1 Year
Success Rate
6/9 ratings generated profit
Average Return
+21.57%
reiterated a buy rating 3 months ago
Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +21.57% per trade.
2 Years
xxx
Success Rate
16/23 ratings generated profit
Average Return
+102.37%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 69.57% of your transactions generating a profit, with an average return of +102.37% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BNTC Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Sep 25
Nov 25
Strong Buy
6
2
2
4
6
Buy
4
2
4
5
7
Hold
1
1
3
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
5
9
12
15
Each month's total comprises the sum of three months' worth of ratings.
BNTC Financial Forecast
BNTC Stock Forecast FAQ
What is BNTC’s average 12-month price target, according to analysts?
Based on analyst ratings, Benitec Biopharma Ltd’s 12-month average price target is 26.00.
What is BNTC’s upside potential, based on the analysts’ average price target?
Benitec Biopharma Ltd has 128.47% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BNTC a Buy, Sell or Hold?
Benitec Biopharma Ltd has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Benitec Biopharma Ltd’s price target?
The average price target for Benitec Biopharma Ltd is 26.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $32.00 ,the lowest forecast is $20.00. The average price target represents 128.47% Increase from the current price of $11.38.
The highest analyst price target is $32.00 ,the lowest forecast is $20.00. The average price target represents 128.47% Increase from the current price of $11.38.
What do analysts say about Benitec Biopharma Ltd?
Benitec Biopharma Ltd’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of BNTC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.